Skip to main content
TipRanks
Go Ultimate75% OFF

Avenue Therapeutics (ATXI) Income Statement

334 Followers

Avenue Therapeutics Income Statement

Last quarter (Q3 2026), Avenue Therapeutics's total revenue was $0.00. In Q3, Avenue Therapeutics's net income was $-691.00K. See Avenue Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 1.40M$ 0.00$ 0.00$ 0.00$ 0.00
$ 1.40M$ 0.00$ 0.00$ 0.00$ 0.00
$ 4.69M$ 11.28M$ 14.54M$ 8.04M$ 3.74M
Depreciation and Amortization$ 0.00$ 0.00$ 14.54M$ 0.00$ 3.74M
$ -3.29M$ -11.70M$ 4.05M$ -2.44M$ 7.00K
$ -3.29M$ -11.28M$ -14.54M$ -8.04M$ -3.74M
$ 339.00K$ -413.00K$ 4.05M$ 4.44M$ 7.00K
$ -2.95M$ -11.70M$ -10.49M$ -3.60M$ -3.73M
$ -2.91M$ -11.65M$ -10.38M$ -3.55M$ -3.73M
Per Share Metrics
Basic EPS$ -0.93$ -0.90$ -73.60$ -121.91$ -3.29
Diluted EPS$ -0.93$ -0.90$ -73.48$ -121.91$ -3.29
Weighted Average Shares Outstanding3.13M12.95M141.00K29.14K1.13M
Weighted Average Shares Outstanding (Diluted)3.13M12.95M141.22K29.14K1.13M

Currency in USD

Avenue Therapeutics Earnings and Revenue History

-30M-15M015M-209 %-208 %-207 %-206 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin